Loading quotes...

Forecast

There is no analyst data available for this company.


  • Getinge hits 52-week high after strong Q2 results

    Getinge reported strong organic growth for Q2 2026, an adjusted EBITA margin of 17.6% supported by a customs refund of about SEK 336m as well as a favorable product mix, price adjustments and productivity improvements. CEO Mattias Perjos described the quarter as financially and operationally strong; Acute Care Therapies and Surgical Workflows showed growth, while Life Science was mixed with double-digit growth in Sterile Transfer but weakness in WIS. Management reaffirmed the full-year guidance for organic revenue growth of 3–5% for 2026. The stock rose 7.1% today to a 52-week high of SEK 232.2. » More on de.investing.com


  • Getinge reports organic growth in Q4 2025 — margins hit by currency and tariffs

    Getinge recorded organic sales growth of 1.2% in the fourth quarter of 2025 and an organic order intake increase of 2.3%. The adjusted EBITA margin fell to 17.8% from 19.4% a year earlier. Management attributes the margin pressure to strong currency and tariff effects (−464 million SEK in Q4, −1,052 million SEK for the full year). The company generated free cash flow of 1.6 billion SEK, proposes a dividend of 4.75 SEK, and reports net debt of 1.5x adjusted EBITDA (1.2x excluding pension liabilities). For 2026 Getinge expects organic sales growth of 3–5% and confirms the target of an adjusted EBITA margin of 16–19% for 2028. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics
In 2026, Getinge B has already paid €0.44 in dividends. The last payout was in April.

Financials

In the last quarter, Getinge B had revenue of €744.96m and net profit of €63.51m
(EUR) September 2026
YoY
Revenue 744.96m 0.10%
Gross profit 336.49m 5.25%
Net profit 63.51m 24.02%
EBITDA 149.59m 12.79%

Fundamentals

Metric Value
Market capitalization
€6.58bn
Number of shares
274.87m
52-week high/low
€24.17 - €15.85
Dividend yield
1.82%
Dividends TTM
€0.44
Beta
0.73
P/E ratio
25.56
PEG ratio
0.68
P/B ratio
2.22
P/S ratio
2.10

Company profile

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, logistic automation solutions, bioreactors, bioprocess control systems, bioprocess software, biobundles, bioprocess analytics, and perfusion systems; practice-oriented monitoring systems and disposables, anesthesia machines, beating heart stabilizers and positioners, axius blower mister and coronary shunts, proximal seal systems, ceiling supply units, connected solutions, cleaning and disinfection products, packaging and sealing solutions, monitors and indicators, and SteriTec products. The company also provides thoracic catheters, dry seal chest drain, mobile dry seal drain, dry and wet suction water seal chest drain, and chest drain valves; transitional accessories; endoscope reprocessing; endoscopic vessel harvesting systems; endovascular products; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packing products; intra-aortic balloon counter pulsation therapies; mechanical ventilation products; medical furniture; modular room systems; operating lights and tables; OR integration and management; patient flow management; patient transport; sterile supply management; sterilization; surgical assist systems; surgical perfusion; transport & storage; trays & baskets; and vascular and cardiothoracic surgery solutions. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Name
Getinge B
CEO
Mattias Perjos
Headquarters Gothenburg, vg
Sweden
Website
Sector
Health Care
Industry
Health Care Technology
IPO
25/06/2020
Employees 12,118

Ticker symbols

Exchange Symbol
Iob
0GZV.IL
Sto
GETI-B.ST
Pnk
GNGBF
Frankfurt
GTN.F
Düsseldorf
GTN.DU
London
0GZV.L
Stockholm
GETI B.ST
SIX
GETIB.SW
München
GTN.MU
🍪

Parqet  uses cookies. Learn more